Ghada El-Hajj Fuleihan, MD, MPH

Dr. Ghada El-Hajj Fuleihan is the founding Director of the Calcium Metabolism and Osteoporosis Program (1997), WHO Collaborating Center for Metabolic Bone Disorders (2010), and Founding/Program Director of the Scholars in HeAlth Research Program funded by an NIH-FIC D43 grant scheme.

Her research laboratory, at the Brigham and Women’s Hospital, Boston, focused on investigating modulators of the signal transduction pathways and calcium-sensing by the parathyroid gland, kidney and pituitary. She also served as PI on phase II and III osteoporosis trials. Her work in Lebanon focused on epidemiologic osteoporosis studies, and vitamin D intervention trials, across the lifecycle, and in disease states such as epilepsy and cancer. The evidence provided, through randomized trials, systematic reviews, and meta-analyses, has led to guidelines nationally and internationally. Recent investigations focus on linking fat and bone metabolism with a translational approach. Dr. El-Hajj Fuleihan has a total of over 190 publications (80 over the last 9 years (2012-2020)), 8 peer reviewed protocols, 12 invited editorials/commentaries, including 3 in the NEJM and 4 in Nature Reviews Endocrinology, 21 position papers and clinical guidelines, 28 invited reviews, and 16 book chapters in major reference textbooks. Her H-index is 51 by Scopus and 49 by Web of Science.